10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-35955

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	04-3392453
State or other jurisdiction of incorporation or organization	(I.R.S. Employer Identification No.)

25 Hendrix Road, Suite A West Henrietta, New York	14586
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (585) 359-5900

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	Trading Symbol(s)	Name of each exchange on which registered:
Common Stock, par value $0.001	VUZI	Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.   Yes  ☒    No  ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  ⌧    No  ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐
Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

As of May 10, 2022, there were 63,667,941 shares of the registrant’s common stock outstanding.

Vuzix Corporation

INDEX

		Page No.
Part I – Financial Information
Item 1.	Consolidated Financial Statements (Unaudited):	3
	Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021	3
	Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2022 and 2021	4
	Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021	5
	Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021	6
	Notes to the Unaudited Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
Part II – Other Information		23
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24
Item 3.	Defaults Upon Senior Securities	24
Item 4.	Mine Safety Disclosure	24
Item 5.	Other Information	24
Item 6.	Exhibits	25
Signatures		26

2

Part 1: FINANCIAL INFORMATION

Item 1: Consolidated Financial Statements

VUZIX CORPORATION

CONSOLIDATED BALANCE SHEETS

	(Unaudited)
	March 31,		December 31,
	2022		2021
ASSETS
Current Assets
Cash and Cash Equivalents	$	113,329,734	$	120,203,873
Accounts Receivable		1,551,654		2,242,429
Inventories, Net		12,559,066		12,151,982
Manufacturing Vendor Prepayments		586,564		504,051
Prepaid Expenses and Other Assets		1,470,415		2,047,819
Total Current Assets		129,497,433		137,150,154
Long-Term Assets
Fixed Assets, Net		5,042,421		5,190,438
Operating Lease Right-of-Use Asset		968,269		1,117,022
Patents and Trademarks, Net		2,020,099		1,988,370
Licenses, Net		1,333,236		1,389,936
Intangible Asset, Net		42,821		147,548
Other Assets, Net		1,445,897		1,483,589
Total Assets	$	140,350,176	$	148,467,057
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts Payable	$	1,223,741	$	2,054,762
Unearned Revenue		29,623		27,797
Accrued Expenses		1,127,021		1,419,308
Income and Other Taxes Payable		45,692		120,242
Operating Lease Right-of-Use Liability		514,204		534,146
Total Current Liabilities		2,940,281		4,156,255
Long-Term Liabilities
Operating Lease Right-of-Use Liability		454,065		582,876
Total Liabilities		3,394,346		4,739,131
Stockholders' Equity
Common Stock - $0.001 Par Value, 100,000,000 Shares Authorized; 63,704,626 shares issued and 63,667,941 shares outstanding as of March 31, 2022 and 63,672,268 shares issued and outstanding as of December 31, 2021.		63,705		63,672
Additional Paid-in Capital		350,721,326		346,736,397
Accumulated Deficit		(213,578,144)		(203,072,143)
Treasury Stock, at cost, 36,685 shares as of March 31, 2022 and 0 shares as of December 31, 2021		(251,057)		—
Total Stockholders' Equity		136,955,830		143,727,926
Total Liabilities and Stockholders' Equity	$	140,350,176	$	148,467,057

The accompanying notes are an integral part of these consolidated financial statements.

3

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

	Preferred Stock			Common Stock			Additional		Accumulated		Treasury Stock
	Shares	Amount		Shares	Amount		Paid-In Capital		Deficit		Shares	Amount		Total
Balance - January 1, 2022	—	$	—	63,672,268	$	63,672	$	346,736,397	$	(203,072,143)	—	$	—	$	143,727,926
Stock-Based Compensation Expense	—		—	—		—		3,955,738		—	—		—		3,955,738
Stock Option Exercises	—		—	32,358		33		29,191		—	—		—		29,224
Purchases of Treasury Stock	—		—	—		—		—		—	(36,685)		(251,057)		(251,057)
Net Loss	—		—	—		—		—		(10,506,001)	—		—		(10,506,001)
Balance - March 31, 2022	—	$	—	63,704,626	$	63,705	$	350,721,326	$	(213,578,144)	(36,685)	$	(251,057)	$	136,955,830

	Preferred Stock			Common Stock			Additional		Accumulated		Treasury Stock
	Shares	Amount		Shares	Amount		Paid-In Capital		Deficit		Shares	Amount		Total
Balance - January 1, 2021	49,626	$	50	45,645,166	$	45,645	$	210,952,473	$	(162,694,983)	—	$	—	$	48,303,185
Stock-Based Compensation Expense	—		—	—		—		2,047,378		—	—		—		2,047,378
Stock Option Exercises	—		—	230,968		231		196,597		—	—		—		196,828
Stock Warrant Exercises	—		—	7,241,028		7,241		34,561,297		—	—		—		34,568,538
Proceeds from Common Stock Offerings	—		—	4,146,342		4,146		84,995,865		—	—		—		85,000,011
Direct Costs of Common Stock Offerings	—		—	—		—		(5,396,139)		—	—		—		(5,396,139)
Shared Redeemed to Cover Employee Tax Withholdings	—		—	(83,164)		(83)		(1,144,283)		—	—		—		(1,144,366)
Preferred Stock Converted & Preferred Dividend Settlement	(49,626)		(50)	4,962,600		4,962		(10,004,912)		—	—		—		(10,000,000)
Net Loss (as Restated)	—		—	—		—		—		(9,151,370)	—		—		(9,151,370)
Balance - March 31, 2021 (as Restated)	—	$	—	62,142,940	$	62,142	$	316,208,276	$	(171,846,353)	—	$	—	$	144,424,065

The accompanying notes are an integral part of these consolidated financial statements.

4

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended March 31,
			(as Restated)
	2022		2021
Sales:
Sales of Products	$	2,503,051	$	3,805,170
Sales of Engineering Services		—		110,219
Total Sales		2,503,051		3,915,389
Cost of Sales:
Cost of Sales - Products Sold		1,863,697		2,819,971
Cost of Sales - Engineering Services		—		15,827
Total Cost of Sales		1,863,697		2,835,798
Gross Profit (exclusive of depreciation shown separately below)		639,354		1,079,591
Operating Expenses:
Research and Development		3,103,444		2,205,318
Selling and Marketing		2,023,435		1,303,430
General and Administrative		5,453,833		6,027,757
Depreciation and Amortization		422,931		517,412
Loss on Fixed Asset Disposal		—		83,908
Impairment of Patents and Trademarks		49,603		27,731
Total Operating Expenses		11,053,246		10,165,556
Loss From Operations		(10,413,892)		(9,085,965)
Other Income (Expense):
Investment Income		6,280		7,838
Income and Other Taxes		(47,632)		(19,725)
Foreign Exchange Loss		(50,757)		(53,518)
Total Other Expense, Net		(92,109)		(65,405)
Loss Before Provision for Income Taxes		(10,506,001)		(9,151,370)
Provision for Income Taxes		—		—
Net Loss		(10,506,001)		(9,151,370)
Basic and Diluted Loss per Common Share	$	(0.16)	$	(0.17)
Weighted-average Shares Outstanding - Basic and Diluted		63,695,127		54,141,761

The accompanying notes are an integral part of these consolidated financial statements.

5

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended March 31,
			(as Restated)
	2022		2021
Cash Flows from Operating Activities
Net Loss	$	(10,506,001)	$	(9,151,370)
Non-Cash Adjustments
Depreciation and Amortization		422,931		517,412
Amortization of Software Development Costs and Prepaid Licenses in Cost of Sales - Products		60,099		60,099
Stock-Based Compensation		4,319,748		4,618,213
Impairment of Patents and Trademarks		49,603		27,731
Loss on Fixed Asset Disposal		—		83,908
(Increase) Decrease in Operating Assets
Accounts Receivable		690,775		91,973
Revenues in Excess of Billings		—		(40,856)
Inventories		(407,084)		(857,695)
Manufacturing Vendor Prepayments		(82,513)		(1,785,763)
Prepaid Expenses and Other Assets		213,394		142,685
Increase (Decrease) in Operating Liabilities
Accounts Payable		(831,021)		(191,028)
Accrued Expenses		(292,286)		646,048
Unearned Revenue		1,825		(17,698)
Income and Other Taxes		(74,549)		(65,288)
Net Cash Flows Used in Operating Activities		(6,435,079)		(5,921,629)
Cash Flows from Investing Activities
Purchases of Fixed Assets		(57,758)		(314,981)
Investments in Patents and Trademarks		(34,469)		(135,674)
Investments in Licenses, Intangible and Other Assets		(125,000)		(200,000)
Net Cash Flows Used in Investing Activities		(217,227)		(650,655)
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants		—		34,568,538
Proceeds from Exercise of Stock Options		29,224		196,828
Proceeds from Common Stock Offering, Net		—		79,603,872
Purchases of Treasury Stock		(251,057)		—
Preferred Dividend Settlement Payment		—		(10,000,000)
Employee Tax Withholdings Payment		—		(1,144,366)
Net Cash Flows (Used in) Provided from Financing Activities		(221,833)		103,224,872
Net (Decrease) Increase in Cash and Cash Equivalents		(6,874,139)		96,652,588
Cash and Cash Equivalents - Beginning of Period		120,203,873		36,069,508
Cash and Cash Equivalents - End of Period	$	113,329,734	$	132,722,096
Supplemental Disclosures
Unamortized Common Stock Expense included in Prepaid Expenses and Other Assets	$	1,001,232	$	160,222
Stock-Based Compensation Expense - Expensed less Previously Issued		364,010		58,828

The accompanying notes are an integral part of these consolidated financial statements.

6

VUZIX CORPORATION

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements of Vuzix Corporation (“the Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, the unaudited consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Certain re-classifications may have been made to prior periods to conform with current reporting. The results of the Company’s operations for the three months ended March 31, 2022 are not necessarily indicative of the results of the Company’s operations for the full fiscal year or any other period.

The accompanying interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto of the Company as of December 31, 2021, as reported in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2022.

Restatement

As described in additional detail in Note 14 to the financial statements included in its 2021 Form 10-K, the Company restated its previous unaudited quarterly results in the Form 10-K for the year ended December 31, 2021. Previously filed 2021 quarterly reports on Form 10-Q for the periods affected by the restatement were not amended. See Note 14, Long-Term Incentive Plan and Note 19, Quarterly Financial Information (Unaudited) of the Notes to the consolidated financial statements in the 2021 Form 10-K for the impact of these adjustments on each of the quarterly periods in fiscal year 2021.

The effect of these changes on non-cash stock-based compensation expense included in 2021 unaudited quarterly operating results was as follows:

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05

Customer Concentrations

For the three months ended March 31, 2022, one customer represented 11% of total product revenue. For the three months ended March 31, 2021, one customer represented 11% of total product revenue and one customer represented 100% of engineering services revenue.

As of March 31, 2022, three customers represented 22%, 14% and 13% of accounts receivable. As of December 31, 2021, three customers represented 27%, 20% and 10% of accounts receivable.

7

Treasury Stock

Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains and losses on the subsequent reissuance of shares will be credited or charged to paid-in capital in excess of par value using the average-cost method.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). ASU 2016-13 provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets and certain other instruments, including but not limited to accounts receivable. ASU 2016-13 will become effective for the Company on January 1, 2023 and early adoption is permitted. The Company does not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

Note 2 – Revenue Recognition and Contracts with Customers

Disaggregated Revenue

The Company’s total revenue was comprised of two major product lines: Smart Glasses Sales and Engineering Services. The following table summarizes the revenue recognized by major product line:

	Three Months Ended
	March 31,
	2022		2021
Revenues
Smart Glasses Sales	$	2,503,051	$	3,805,170
Engineering Services		—		110,219
Total Revenue	$	2,503,051	$	3,915,389

Significant Judgments

Under Topic 606 “Revenue from Contracts with Customers”, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized by major product line. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include an end-user 30-day right to return if not satisfied with product and general payment terms that are between Net 30 and 60 days. For our engineering services, performance obligations are recognized over time using the input method and the estimated costs to complete each project are considered significant judgments.

Performance Obligations

Revenues from our performance obligations are typically satisfied at a point in time for Smart Glasses, Waveguides and Display Engines, and our OEM Products, which are recognized when the customer obtains control and ownership, which is generally upon shipment. The Company also records revenue for performance obligations relating to our engineering services over time by using the input method measuring progress toward satisfying the performance obligations. Satisfaction of our performance obligations related to our engineering services is measured by the Company’s costs incurred as a percentage of total expected costs to project completion as the inputs of actual costs incurred by the Company are directly correlated with progress toward completing the contract. As such, the Company believes that our methodologies for recognizing revenue over time for our engineering services correlate directly with the transfer of control of the underlying assets to our customers.

8

Our standard product sales include a twelve (12) month assurance-type product warranty. In the case of certain of our OEM products and waveguide sales, some include a standard product warranty of up to eighteen (18) months to allow distribution channels to offer the end customer a full twelve (12) months of coverage. We offer extended warranties to customers, which extend the standard product warranty on product sales for an additional twelve (12) month period. All revenue related to extended product warranty sales is deferred and recognized over the extended warranty period. Our engineering services contracts vary from contract to contract but typically include payment terms of Net 30 days from date of billing, subject to an agreed upon customer acceptance period.

The following table presents a summary of the Company’s sales by revenue recognition method as a percentage of total net sales for the three months ended March 31, 2022:

	% of Total Net Sales
	2022		2021
Point-in-Time	100	%	97	%
Over Time – Input Method	-	%	3	%
Total	100	%	100	%

Remaining Performance Obligations

As of March 31, 2022, the Company had no outstanding performance obligations for its engineering services and waveguide development projects. In addition, the Company had no material outstanding performance obligations related to product sales, other than its standard product warranty.

Note 3 – Loss Per Share

Basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are anti-dilutive. Since the Company reported a net loss for the three months ended March 31, 2022 and 2021, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. At March 31, 2022 and 2021, there were 8,611,365 and 8,983,727 common stock share equivalents, respectively, potentially exercisable or issuable under conversion or exercise of stock options that could dilute basic earnings per share in the future.

Note 4 – Inventories, Net

Inventories are stated at the lower of cost and net realizable value, and consisted of the following:

	March 31,		December 31,
	2022		2021
Purchased Parts and Components	$	11,461,309	$	11,580,766
Work-in-Process		265,757		226,126
Finished Goods		1,959,141		1,472,534
Less: Reserve for Obsolescence		(1,127,141)		(1,127,444)
Inventories, Net	$	12,559,066	$	12,151,982

9

Note 5 – Licenses, Net

	March 31,		December 31,
	2022		2021
Licenses	$	2,443,356	$	1,038,606
Additions		—		1,404,750
Less: Accumulated Amortization		(1,110,120)		(1,053,420)
Licenses, Net	$	1,333,236	$	1,389,936

The Company acquired two licenses in 2017. The first related to the renegotiation of an existing license at a cost of $114,967, which resulted in lower royalty rates being paid by the Company over the next ten years. This license went into effect as of January 1, 2018. The second license was a result of the Company entering into a Technology Purchase and Royalty Agreement where it acquired all the seller’s right, title and interest in certain Transferred Intellectual Property (IP). Pursuant to the agreement, the Company paid approximately $75,702 as reimbursement of related patent application costs incurred by the seller to date, which are included in Patents and Trademarks. The Company also issued 25,000 shares of common stock, valued at $128,750, upon the original closing in October 2017 and agreed to certain further share issuances of 75,000 shares based upon the achievement of certain development milestones as well as per unit royalties once the technology was commercialized for the life of the related patents. In June 2021, the Company assumed or purchased outright the obligations for ongoing royalties under the original license agreement and certain other intellectual property rights in connection with consulting services by the original seller in exchange for the issuance of 75,000 shares with an assigned market value of $18.73 per share, or a total of $1,404,750. The underlying technology is not yet ready for commercialization, but the Company intends to proceed with further research and development work relating to such underlying technology.

Note 6 – Intangible Asset, Net

	March 31,		December 31,
	2022		2021
Intangible Asset	$	1,500,000	$	1,500,000
Less: Accumulated Amortization		(1,457,179)		(1,352,452)
Intangible Asset, Net	$	42,821	$	147,548

On October 4, 2018, the Company entered into amendment No. 1 to agreements (the “TDG Amendment”) with TDG Acquisition Company, LLC (“TDG”), aka Six15 Technologies, LLC. The TDG Amendment amends certain provisions of prior agreements between Vuzix and TDG, including an asset purchase agreement dated June 15, 2012, and an authorized reseller agreement dated June 15, 2012.

Pursuant to the TDG Amendment, the Company is permitted to engage in sales of heads-up display components or subsystems (and any services to support such sale) for incorporation into a finished good or system for sale to military organizations, subject to certain conditions. The Company is also permitted to sell its products to defense and security organizations that include business customers and governmental entity customers that primarily provide security and defense services, including police, fire fighters, EMTs, other first responders, and homeland and border security. The Company will owe TDG commissions with respect to all such sales until June 15, 2022, when the amendment and original non-compete agreements expire, after which the Company will be permitted to sell any product to any customer world-wide without owing any commission to TDG.

Total commissions expense under this agreement for the three months ended March 31, 2022 and 2021 was $25,794 and $52,655. All commissions expense related to this agreement is included in Selling and Marketing expense.

Total amortization expense for this intangible asset for the three months ended March 31, 2022 and 2021 was $104,727 and $104,727, respectively. $42,821 of remaining amortization expense will be recognized in the second quarter of 2022, as the non-compete agreement with TDG expires on June 15, 2022.

10

Note 7 - Other Assets

	March 31,		December 31,
	2022		2021
Private Corporation Investments (at cost)	$	450,000	$	450,000
Software Development Costs		750,000		500,000
Additions		125,000		250,000
Less: Accumulated Amortization		(250,000)		(208,334)
Software Development Costs, Net		625,000		541,666
Unamortized Common Stock Expense included in Long-Term Prepaid Expenses		370,897		491,923
Total Other Assets	$	1,445,897	$	1,483,589

During 2020, the Company invested $500,000 in Android operating systems upgrades for its CPU platform used on its M400 and M4000 products. This upgrade was finished and placed into service in the beginning of the fourth quarter of 2020.  This capitalized asset is being amortized on a straight-line over its expected product life cycle of 36 months, which began on October 1, 2020. In October 2021, the Company invested $250,000 and in the first quarter of 2022 the Company invested an additional $125,000 for further Android operating systems version upgrades to the CPU platform it uses on its M400 and M4000 products. This development work has not yet been completed and will ultimately be amortized once placed into service which the Company expects to occur by early 2023.

Note 8 – Accrued Expenses

Accrued expenses consisted of the following:

	March 31,		December 31,
	2022		2021
Accrued Wages and Related Costs	$	484,980	$	683,044
Accrued Professional Services		318,231		551,220
Accrued Warranty Obligations		156,192		185,044
Other Accrued Expenses		167,618		—
Total	$	1,127,021	$	1,419,308

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally twelve (12) months. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued expense at the time of sale. The Company estimates its future warranty costs based upon product-based historical performance rates and related costs to repair.

The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2022 and the balance as of December 31, 2021 were as follows:

Accrued Warranty Obligations at December 31, 2021	$	185,044
Reductions for Settling Warranties		(103,943)
Warranties Issued During Year		75,091
Accrued Warranty Obligations at March 31, 2022	$	156,192

11

Note 9 – Income Taxes

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

Note 10 – Capital Stock

Preferred stock

The Board of Directors is authorized to establish and designate different series of preferred stock and to fix and determine their voting powers and other rights and terms. A total of 5,000,000 shares of preferred stock with a par value of $0.001 are authorized as of March 31, 2022 and December 31, 2021. Of this total, 49,626 shares are designated as Series A Preferred Stock. There were nil shares of Series A Preferred Stock issued and outstanding on March 31, 2022 and December 31, 2021, respectively.

Common Stock

The Company’s authorized common stock consists of 100,000,000 shares, par value of $0.001. There were 63,704,626 shares issued and 63,667,941 shares outstanding as of March 31, 2022 and 63,672,268 shares issued and outstanding as of December 31, 2021.

Treasury Stock

On March 2, 2022, our Board of Directors approved the repurchase by the Company of up to an aggregate of $25 million of our common stock by open market or privately negotiated transactions under the Share Buyback Program.  This program is in effect for one year, does not obligate the Company to acquire any particular amount of common stock and  may be suspended or discontinued at any time at the Company’s sole discretion. During the three months ended March 31, 2022, the Company repurchased 36,685 shares of our common stock at an average cost of $6.84. As of March 31, 2022, 36,685 shares of our common stock were held in treasury.

Note 11 – Stock-Based Compensation

A summary of stock option activity related to the Company’s standard employee incentive plan, excluding options awarded under the Long-Term Incentive Plan (LTIP), for the three months ended March 31, 2022 is as follows:

		Weighted
	Number of	Average
	Options	Exercise Price
Outstanding at December 31, 2021	2,823,634	$	7.67
Granted	98,500		5.78
Exercised	(43,040)		3.94
Expired or Forfeited	(51,729)		8.60
Outstanding at March 31, 2022	2,827,365	$	7.74

The weighted average remaining contractual term for all options as of March 31, 2022 and December 31, 2021 was 7.74 years and 7.95 years, respectively.

As of March 31, 2022, there were 1,183,727 options that were fully-vested and exercisable at a weighted average exercise price of $6.04 per share. The weighted average remaining contractual term of the vested options is 6.6 years.

As of March 31, 2022, there were 1,643,638 unvested options exercisable at a weighted average exercise price of $9.83 per share. The weighted average remaining contractual term of the unvested options is 8.6 years.

12

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At March 31, 2022, the Company had $8,353,781 of unrecognized stock compensation expense, which will be recognized over a weighted average period of 3.0 years.

For the three months ended March 31, 2022 and 2021, the Company recorded total stock-based compensation expense, including stock awards but excluding awards under the Company’s LTIP, of $1,350,610 and $456,745, respectively.

Note 12 – Long-Term Incentive Plan

On March 17, 2021, the Company granted options to purchase a total of 5,784,000 shares of common stock to its officers and certain other members of its management team. The options were granted under the Company’s existing 2014 Incentive Stock Plan. The options have an exercise price of $19.00, with 375,000 options vesting immediately and the remaining portion vesting upon the achievement of certain equity market capitalization milestones, and revenue and EBITDA operational milestones. For the three months ended March 31, 2022 and 2021, the Company recorded non-cash stock-based compensation expense of $2,969,138 and $4,161,468, respectively, for options that vested or are probable to vest.

The fair value of option grants was calculated using a Monte Carlo simulation on the equity market capitalization tranches and the Black-Scholes-Merton option pricing method on the operational milestone tranches. As of March 31, 2022, we had $25,371,320 of total unrecognized stock-based compensation expense for the portion of options tied to equity market capitalization milestones and the portion of options tied to operational milestones that were considered probable of achievement, all of which will be recognized over a service period of up to six years. The probabilities of the milestone achievements are subject to catch-adjustments in each instance where an equity market capitalization milestone is achieved or when an operational milestone becomes probable to be achieved or is achieved. Compensation costs could be reversed in subsequent periods if an awardee leaves the Company prior to the expiration of the option life for market capitalization milestone or the performance awards are no longer determined to be probable. If such milestones are achieved earlier in their expected service periods, the remaining unrecognized compensation expense related to that particular milestone would be accelerated and recognized in full during the period where that achievement is affirmed by the Board of Directors. As of March 31, 2022, and going forward, should all of the operational milestones which are currently not yet deemed probable of achievement become probable of achievement or are achieved, then the Company could ultimately recognize up to an additional $34.1 million in non-cash stock-based compensation expense at such time.

The unvested remaining equity market capitalization and operational milestones under the LTIP with their total related option grants and criteria achievement weightings of the options available for meeting a target are shown in the following table. Of the total 5,409,000 unvested options outstanding as of March 31, 2022 and December 31, 2021, there are 2,704,500 options unvested for the achievement of equity market capitalization targets, 1,893,150 unvested options

13

for the achievement of annual revenue targets, and 811,350 unvested options for the achievement of annual EBITDA margins before non-cash charges targets.

Award Potential	Criteria Achievement Weighting
	50% of Options Available	35% of Options Available	15% of Options Available
Options Available (Subject to Vesting)	Equity Market Capitalization Target	Last Twelve Months Revenue Target	Last Twelve Months EBITDA Margin before Non-Cash Charges Target
686,000	$ 2,000,000,000	$ 25,000,000	0.0%
686,000	3,000,000,000	50,000,000	2.0%
686,000	4,000,000,000	100,000,000	4.0%
686,000	5,000,000,000	200,000,000	6.0%
586,000	6,000,000,000	300,000,000	8.0%
586,000	7,000,000,000	450,000,000	10.0%
561,000	8,000,000,000	675,000,000	12.0%
491,000	9,000,000,000	1,000,000,000	14.0%
441,000	10,000,000,000	1,500,000,000	16.0%
5,409,000

Note 13 – Litigation

We are not currently involved in any actual or pending legal proceeding or litigation and we are not aware of any such material proceedings contemplated by or against us or involving our property.

Note 14 – Right-of-Use Assets and Liabilities

Future lease payments under operating leases as of March 31, 2022 were as follows:

2022	$	417,750
2023		546,916
2024		45,576
Total Future Lease Payments		1,010,242
Less: Imputed Interest		(41,973)
Total Lease Liability Balance	$	968,269

Operating lease costs under the operating leases totaled $162,365 and $124,215 for the three months ended March 31, 2022 and 2021, respectively.

As of March 31, 2022, the weighted average discount rate was 4.5% and the weighted average remaining lease term was 1.8 years.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this quarterly report and in our Annual Report on Form 10-K for the year ended December 31, 2021.

As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix”, “management,” “we,” “our,” and “us” refer to Vuzix Corporation.

Critical Accounting Policies and Significant Developments and Estimates

The discussion and analysis of our financial condition and results of operations is based on our unaudited consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these

14

statements in conformity with GAAP requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our consolidated financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, bad debts, inventories, warranty reserves, product warranty, carrying value of long-lived assets, fair value measurement of financial instruments, valuation of stock compensation awards, achievement of equity market capitalization and probability of operational milestones being achieved under our LTIP, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the consolidated financial statements.

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate these accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

Management believes certain factors and trends are important in understanding our financial performance. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our consolidated financial statements are:

● Valuation of inventories;

● Carrying value of long-lived assets;

● Software development costs;

● Revenue recognition;

● Product warranty;

● Stock-based compensation; and

● Income taxes.

Our accounting policies are more fully described in the notes to our consolidated financial statements included in this quarterly report and in our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes in our accounting policies for the three months ended March 31, 2022.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.

Business Matters

We are engaged in the design, manufacture, marketing and sale of wearable computing devices and augmented reality wearable display devices, also referred to as head mounted displays (or HMDs), heads-up displays (HUDs) or near-eye displays, in the form of Smart Glasses and Augmented Reality (AR) glasses. Our wearable display devices are worn like eyeglasses or attach to a head-worn mount. These devices typically include cameras, sensors, and a computer that enable the user to view, record and interact with video and digital content, such as computer data, the Internet, social media or entertainment applications. Our wearable display products integrate display technology with our advanced optics to produce compact high-resolution display engines, less than half an inch diagonally, which when viewed

15

through our Smart Glasses products create virtual images that appear comparable in size to that of a computer monitor or a large-screen television.

With respect to our Smart Glasses and AR products, we are focused on the enterprise, industrial, commercial, security, first responder, medical markets, and, to a lesser degree, defense markets. We also provide custom solutions and engineering services to third parties, including OEMs, of waveguides to enable fully integrated wearable display systems, including HMDs to commercial, industrial and defense customers. We do not offer “work for hire” services per se but rather offer our engineering services for projects that we expect could result in advancing our technology and potentially lead to long-term supply or OEM relationships.

All of the mobile displays and wearable and mobile electronics markets in which we compete, including mobile and wearable displays and electronics, have been and continue to be subject to consistent and rapid technological change, with ever greater capabilities and performance, including mobile devices with larger screen sizes and improved display resolutions as well as, in many cases, declining prices on mobile devices. As a result, we must continue to improve our products’ performance and lower our costs. We believe our intellectual property portfolio gives us a leadership position in the design and manufacturing of micro-display projection engines, waveguides, mechanical packaging, ergonomics, and optical systems.

Recent Accounting Pronouncements

See Note 1 to the consolidated financial statements.

16

Results of Operations

Comparison of Three Months Ended March 31, 2022 and 2021

The following table compares the Company’s consolidated statements of operations data for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
							Dollar		% Increase
	2022			2021			Change		(Decrease)
					(as Restated)
Sales:
Sales of Products	$	2,503,051		$	3,805,170		$	(1,302,119)	(34)	%
Sales of Engineering Services		—			110,219			(110,219)	(100)	%
Total Sales		2,503,051			3,915,389			(1,412,338)	(36)	%
Cost of Sales:
Cost of Sales - Products Sold		1,863,697			2,819,971			(956,274)	(34)	%
Cost of Sales - Engineering Services		—			15,827			(15,827)	(100)	%
Total Cost of Sales		1,863,697			2,835,798			(972,101)	(34)	%
Gross Profit (exclusive of depreciation shown separately below)		639,354			1,079,591			(440,237)	(41)	%
Gross Profit %		26	%		28	%
Operating Expenses:
Research and Development		3,103,444			2,205,318			898,126	41	%
Selling and Marketing		2,023,435			1,303,430			720,005	55	%
General and Administrative		5,453,833			6,027,757			(573,924)	(10)	%
Depreciation and Amortization		422,931			517,412			(94,481)	(18)	%
Impairment of Patents and Trademarks		49,603			27,731			21,872	79	%
Loss on Fixed Asset Disposal		—			83,908			(83,908)	(100)	%
Loss from Operations		(10,413,892)			(9,085,965)			(1,327,927)	15	%
Other Income (Expense):
Investment Income		6,280			7,838			(1,558)	(20)	%
Income and Other Taxes		(47,632)			(19,725)			(27,907)	141	%
Foreign Exchange Loss		(50,757)			(53,518)			2,761	(5)	%
Total Other Expense, Net		(92,109)			(65,405)			(26,704)	41	%
Net Loss	$	(10,506,001)		$	(9,151,370)		$	(1,354,631)	15	%

17

Sales.   There was a decrease in total sales for the three months ended March 31, 2022 compared to the same period in 2021 of $1,412,338 or 36%. The following table reflects the major components of our sales:

	Three Months Ended		% of		Three Months Ended		% of		Dollar		% Increase
	March 31, 2022		Total Sales		March 31, 2021		Total Sales		Change		(Decrease)
Sales of Smart Glasses	$	2,379,398	95	%	$	3,772,481	96	%	$	(1,393,083)	(37)	%
Sales of Waveguides & Display Engines		108,250	4	%		—	—	%		108,250	N/M
Sales Freight out		15,403	1	%		32,689	1	%		(17,286)	(53)	%
Sales of Engineering Services		—	—	%		110,219	3	%		(110,219)	(100)	%
Total Sales	$	2,503,051	100	%	$	3,915,389	100	%	$	(1,412,338)	(36)	%

Sales of Smart Glasses products decreased by 37% or $1,393,083 in the three months ended March 31, 2022 compared to the three months ended March 31, 2021. Historically, product revenues in the 1^st quarter of each fiscal year have been noticeably lower than that of the previous three quarters in the prior fiscal year. Product revenues of $2,503,051 in the first quarter of 2022 were significantly higher than comparable periods, with the exception of 2021, which reflected abnormally higher growth over most first quarter comparable periods.

Sales of engineering services for the three months ended March 31, 2022 were nil as compared to $110,219 in the 2021 period.

Cost of Sales and Gross Profit. Cost of product sales and engineering services are comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, and the non-cash amortization of software development costs related to the production of our products and rendering of engineering services. The following table reflects the components of our cost of goods sold for products:

	Three Months Ended		As % Related		Three Months Ended		As % Related		Dollar		% Increase
	March 31, 2022		Product Sales		March 31, 2021		Product Sales		Change		(Decrease)
Product Cost of Sales	$	1,215,736	49	%	$	1,998,514	53	%	$	(782,778)	(39)	%
Freight Costs		208,280	8	%		190,345	5	%		17,935	9	%
Manufacturing Overhead		396,853	16	%		546,673	14	%		(149,820)	(27)	%
Warranty Costs		(28,852)	(1)	%		(32,848)	(1)	%		3,996	(12)	%
Amortization of Software Development Costs		65,880	3	%		64,999	2	%		881	1	%
Software Royalties		5,800	0	%		52,288	1	%		(46,488)	(89)	%
Total Cost of Sales - Products		1,863,697	74	%		2,819,971	74	%		(956,274)	(34)	%
Gross Profit - Product Sales	$	639,354	26	%	$	985,199	26	%	$	(345,845)	(35)	%

For the three months ended March 31, 2022, we reported an overall gross profit from product sales of $639,354 or 26% as compared to $985,199 or 26% in the same period in 2021. On a product cost of sales basis only, product direct costs were 49% of sales in the 2022 period as compared to 53% in 2021.

Manufacturing overhead costs, while decreasing by $149,820 or 27% for the three months ended March 31, 2022 over the 2021 comparable period, increased to 16% as a percentage of total product sales as compared to 14% in 2021. The decrease in the dollar amount of these overhead costs in the current period versus the prior period is primarily due to more absorption of fixed costs being allocated to inventory as a result of improved efficiencies in our manufacturing processes.

18

Costs for engineering services for the three months ended March 31, 2022 were nil as compared to $15,827 in 2021. There was no gross profit from engineering services for the three months ended March 31, 2022 versus $94,392 in the same period in 2021.

Research and Development.  Our research and development expenses consist primarily of compensation costs for personnel, related non-cash stock-based compensation expenses, third-party services, purchase of research supplies and materials, and consulting fees related to research and development. Software development expenses to determine technical feasibility before final development and ongoing maintenance are not capitalized and are included in research and development costs.

					(as Restated)
	Three Months Ended		% of		Three Months Ended		% of		Dollar		% Increase
	March 31, 2022		Total Sales		March 31, 2021		Total Sales		Change		(Decrease)
Research and Development	$	3,103,444	124	%	$	2,205,318	56	%	$	898,126	41	%

Research and development expenses for the three months ended March 31, 2022 increased by $898,126, or 41% as compared to the same period in 2021. This increase was largely due to an increase of $435,356 in external development expenses related to our Next Generation Smart Glasses (Shield); a $358,797 increase in salary and benefits expenses, of which $137,399 was related to non-cash stock-based compensation; and an increase of $52,167 in recruitment and hiring fees.

Selling and Marketing.   Selling and marketing expenses consist of trade show costs, advertising, sales samples, travel costs, sales staff compensation costs including non-cash stock-based compensation expense, consulting fees, public relations agency fees, website costs and sales commissions paid to full-time staff and outside consultants.

					(as Restated)
	Three Months Ended		% of		Three Months Ended		% of		Dollar		% Increase
	March 31, 2022		Total Sales		March 31, 2021		Total Sales		Change		(Decrease)
Selling and Marketing	$	2,023,435	81	%	$	1,303,430	33	%	$	720,005	55	%

Selling and marketing expenses for the three months ended March 31, 2022 increased by $720,005 or 55% as compared to the same period in 2021. This increase was largely due to a $470,857 increase in salary and salary benefits related expense, of which $93,631 was related to non-cash stock-based compensation; an increase of $278,897 in trade show expenses, which was a direct result of attending tradeshows post COVID-19 lockdowns that had benn enforced in 2021; a $100,455 increase in advertising costs; an increase of $27,292 in travel related expenses; partially offset by decreases of $141,829 in website development and maintenance costs and $30,987 in commissions largely due to a reduction in commissions payable to TDG (as described in Note 6 of the financial statements) for defense related engineering services.

General and Administrative.  General and administrative expenses include professional fees, investor relations (IR) costs, salaries and related non-cash stock-based compensation, travel costs, office and rental costs.

					(as Restated)
	Three Months Ended		% of		Three Months Ended		% of		Dollar		% Increase
	March 31, 2022		Total Sales		March 31, 2021		Total Sales		Change		(Decrease)
General and Administrative	$	5,453,833	218	%	$	6,027,757	154	%	$	(573,924)	(10)	%

General and administrative expenses for the three months ended March 31, 2022 decreased by $573,924 or 10% as compared to the same period in 2021. This decrease was largely due to a $594,460 decrease in salary and benefits expenses, related primarily to non-cash stock-based compensation which was significantly higher the first quarter of 2021 due to the vesting of equity market capitalization milestones under the LTIP; a decrease of $101,388 in shareholder related expenses, a $70,111 decrease in recruitment and hiring expenses; a $31,770 decrease in regulatory filings fees; and a $30,384 decrease in legal expenses; partially offset by increases of $177,159 in audit and tax advisory fees and $118,297 in insurance premiums.

19

Depreciation and Amortization.  Depreciation and amortization expense for the three months ended March 31, 2022 was $422,931 as compared to $517,412 in the same period in 2021, a decrease of $94,481. The decrease in depreciation expense is primarily due to certain fixed assets related to machinery and tooling that became fully depreciated in 2021.

Other Expense. Total other expense was $92,109 for the three months ended March 31, 2022 as compared to $65,405 in the same period in 2021, an increase of $26,704. The overall increase in other expenses was primarily the result of an increase of $27,907 in income and other taxes.

Provision for Income Taxes. There was not a provision for income taxes in the respective three month periods ending March 31, 2022 and 2021.

Liquidity and Capital Resources

Capital Resources: As of March 31, 2022, we had cash and cash equivalents of $113,329,734, a decrease of $6,874,139 from $120,203,873 as of December 31, 2021.

As of March 31, 2022, we had current assets of $129,497,433 as compared to current liabilities of $2,940,319 which resulted in a positive working capital position of $126,557,114. As of December 31, 2021, we had a working capital position of $132,993,899. Our current liabilities are comprised principally of accounts payable, accrued expenses and operating lease right-of-use liabilities.

Summary of Cash Flow:

The following table summarizes our select cash flows for the three months ended:

	March 31,		March 31,
	2022		2021
Net Cash Provided by (used in)
Net Loss less Non-Cash Operating Expenses	$	(5,653,620)	$	(3,844,007)
Operating Activities	$	(6,435,079)	$	(5,921,629)
Investing Activities		(217,227)		(650,655)
Financing Activities		(221,833)		103,224,872

During the three months ended March 31, 2022, we used $6,435,042 of cash for operating activities as compared to $5,921,629 for the comparable period in 2021. For the three months ended March 31, 2022, we incurred a net loss of $10,506,001, which, after adding back non-cash operating expenses of $4,852,381, resulted in a net cash loss of $5,653,620 before changes in working capital. For the three months ended March 31, 2021, we incurred a net loss of $9,151,370, which, after adding back non-cash operating expenses of $5,307,363, resulted in a net cash loss of $3,844,007 before changes in working capital. Net changes in working capital items were $781,422 for the three months ended March 31, 2022 with the largest factor resulting from a $1,123,307 reduction in trade accounts payables and other accrued expenses, a $489,597 of investments in inventory and vendor prepayments; partially offset by decreases in accounts receivable of $690,775 and other prepaid expenses of $213,394.

During the three months ended March 31, 2022, we used $217,227 of cash for investing activities, which included $57,758 for purchases of manufacturing equipment and product mold tooling; $34,469 in patent and trademark expenditures; and a further investment of $125,000 in the purchase of software operating license upgrades for our smart glasses platform. For the three months ended March 31, 2021, we used a total of $650,655 in cash for investing activities.

During the three months ended March 31, 2022, we used $221,833 in net cash from financing activities, which included $251,057 of share repurchases under our Share Buyback Program that was announced on March 2, 2022; partially offset by $29,224 in proceeds from the exercise of stock options. For the three months ended March 31, 2021, we received $103,224,872 in proceeds from financing activities, primarily from sales of our equity securities.

20

As of March 31, 2022, the Company does not have any current or long-term debt obligations outstanding.

The Company’s cash requirements are primarily for funding operating losses, working capital, research and development, and capital expenditures. We incurred a net loss for the three months ended March 31, 2022 of $10,506,001 and annual net losses of $40,377,160 (of which $17,302,833 was related to non-cash stock-based compensation, primarily due to our LTIP) in 2021 and $17,952,172 in 2020. The Company has an accumulated deficit of $213,578,144 as of March 31, 2022.

On March 2, 2022, our Board of Directors approved the repurchase by the Company of up to an aggregate of $25 million of our common stock by open market or privately negotiated transactions under the Share Buyback Program. This program is in effect for one year, does not obligate the Company to acquire any particular amount of common stock, and may be suspended or discontinued at any time at the Company’s sole discrestion. During the three months ended March 31, 2022, the Company repurchased 36,685 shares of our common stock at an average cost of $6.84. As of March 31, 2022, 36,685 shares of our common stock were held in treasury.

Our operations are financed primarily through the net proceeds from the sale of our equity securities. As of March 31, 2022, our principal sources of liquidity consisted of cash and cash equivalents of $113,329,734.

Forward Looking Statements

This quarterly report includes forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include, but are not limited to, statements concerning:

● trends in our operating expenses, including personnel costs, research and development expense, sales and marketing expense, and general and administrative expense;

● the effect of competitors and competition in our markets;

● our wearable smart glasses products and their market acceptance and future potential;

● our ability to develop, timely introduce, and effectively manage the introduction of new products and services or improve our existing products and services;

● expected technological advances by us or by third parties and our ability to leverage them;

● our ability to attract and retain customers;

● our ability to accurately forecast consumer demand and adequately manage our inventory;

● our ability to deliver an adequate supply of product to meet demand;

● our ability to maintain and promote our brand and expand brand awareness;

● our ability to detect, prevent, or fix defects in our products;

● our reliance on third-party suppliers, contract manufacturers and logistics providers and our limited control over such parties;

● trends in revenue, costs of revenue, and gross margin and our possible or assumed future results of operations;

● our ability to attract and retain highly skilled employees;

21

● the impact of foreign currency exchange rates;

● the effect of future regulations;

● the sufficiency of our existing cash and cash equivalent balances and cash flow from operations to meet our working capital and capital expenditure needs for at least the next twelve (12) months; and

● general market, political, economic, business and public health conditions.

All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.

All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risk factors include, but are not limited to, those that are described in “Risk Factors” in this report and under Item 1A and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings we make with the Securities and Exchange Commission and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third-party suppliers, limitations of our manufacturing capacity and arrangements, the protection of our proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, liquidity issues, and potential material weaknesses in internal control over financial reporting. Further, during weak or uncertain economic periods, customers may delay the placement of their orders. These factors often result in a substantial portion of our revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter.

We caution readers to carefully consider such factors. Many of these factors are beyond our control. In addition, any forward-looking statements represent our estimates only as of the date they are made and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, except as may be required under applicable securities laws, we specifically disclaim any obligation to do so.

Item 3.Quantitative and Qualitative Disclosures about Market Risk

We invest our excess cash in high-quality short-term corporate debt instruments, which bear lower levels of relative risk. We believe that the effect, if any, of possible near-term changes in interest rates on our financial position, results of operations, and cash flows should not be material to our cash flows or income. It is possible that interest rate movements would increase our unrealized gain or loss on interest rate securities. We are exposed to changes in foreign currency exchange rates primarily through transaction gains and losses as a result of non-U.S. dollar denominated cash flows related to business activities in Japan and Europe. We do not currently hedge our foreign currency exchange rate risk. We estimate that any market risk associated with our international operations is unlikely to have a material adverse effect on our business, financial condition or results of operation.

Item 4.Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management, with the participation of the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), has performed an evaluation of the effectiveness of our disclosure controls and procedures that are defined in Rule 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. This evaluation included consideration of the controls, processes, and procedures that are

22

designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is properly recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting described below and disclosed on the 2021 Form 10-K.

Changes in Internal Control over Financial Reporting

As reported in our assessment of the effectiveness of our internal control over financial reporting as of December 31, 2021, included in “Item 9A. Controls and Procedures” of our Annual Report on Form 10-K for the year ended December 31, 2021, our internal control over financial reporting was considered ineffective as of that date as a result of a material weakness. The material weakness that existed at that time was over the Company’s internal control over financial reporting related to the methodology utilized by the Company to calculate the fair market value of the LTIP stock options issued in March 2021 for the achievement of certain equity market capitalization milestones, and the Company’s subsequent identification and correction of an error in that calculation.

In the first quarter of 2022, we designed and, to the extent possible, implemented control improvements to remediate the material weakness stated above, which include; (i) a more robust and comprehensive review by management each period to identify unusual and non-routine transactions, (ii) a process to identify and engage resources, including third-party resources, with the technical accounting expertise needed to timely address any complex technical accounting issues that affect our consolidated financial statements, and (iii) a more robust process for the selection of third-party specialists and management review of their work.  As of March 31, 2022, not enough time has passed from the implementation of these new procedures to allow for successful control testing that would evidence that this control weakness has been fully remediated.  Management expects to show full remediation of this material weakness in 2022.

Part II. OTHER INFORMATION

Item 1.Legal Proceedings

We are not currently involved in any actual or pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or involving our property.

Item 1A.Risk Factors

In addition to the other information set forth in this report you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no material changes from those risk factors. The risks discussed in our 2021 Annual Report could materially affect our business, financial condition and future results.

Impact of COVID-19 and Geo-political Actions

The implications of COVID-19 and Geo-political actions on our results from operations going forward remain uncertain. These have the ongoing potential to cause adverse effects to our customers, suppliers or business partners in locations that have or will experience more pronounced disruptions, which could result in a reduction to future revenue and manufacturing output as well as delays in our new product development activities. Recent increases in demand for certain chips within various technology sectors and other industries has been one of the ripple effects of the COVID-19 crisis and Geo-political actions that are causing shortages of certain chips and negatively impacting many companies’ supply chains and their ability to maintain or increase their production to meet market demands. At this time, we are operating successfully with our existing products but are seeing longer component lead times which is increasing risk in our supply chain as well as the need to carry more component inventories and make earlier purchase commitments for components, which could have an impact on future products.

23

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Sale of Unregistered Securities – none

Purchase of Equity Securities:

Period	Total number of shares purchased (1)	Average price paid per share (1)		Total number of shares purchased under the Company's Share Buyback Program (1)	Maximum dollar value that may yet be purchased (1)
March 1 - 31, 2022	36,685	$	6.84	36,685	$	24,748,906

(1) On March 2, 2022, our Board of Directors approved the repurchase by the Company of up to an aggregate of $25 million of our common stock by open market or privately negotiated transactions under the Share Buyback Program. This program is in effect for one year, does not obligate the Company to acquire any particular amount of common stock and may be suspended or discontinued at any time at the Company’s sole discretion

Item 3.Defaults Upon Senior Securities

None

Item 4.Mine Safety Disclosures

Not Applicable

Item 5.Other Information

None

24

Item 6.Exhibits

Exhibit No.	Description
31.1	Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2	Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1	Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2	Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Link base Document
101.DEF	Inline XBRL Taxonomy Extension Definition Link base
101.LAB	Inline XBRL Taxonomy Extension Label Link base Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Link base Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

* Filed herewith.

** Furnished herewith

.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VUZIX CORPORATION
Date: May 10, 2022	By:	/s/ Paul Travers
		Paul Travers
		President, Chief Executive Officer
		(Principal Executive Officer)
Date: May 10, 2022	By:	/s/ Grant Russell
		Grant Russell
		Executive Vice President and Chief Financial
		Officer
		(Principal Financial and Accounting Officer)

26

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Paul Travers, certify that:

1.     I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.     The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2022	/s/ Paul Travers
	Paul Travers
	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Grant Russell, certify that:

1.     I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.     The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2022	/s/ Grant Russell
	Grant Russell
	Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Travers, President and Chief Executive Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Paul Travers
	Paul Travers
	President and Chief Executive Officer
Date: May 10, 2022

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Grant Russell, Executive Vice President and Chief Financial Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Grant Russell
	Grant Russell
	Executive Vice President and Chief Financial Officer
Date: May 10, 2022

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 10, 2022
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Entity File Number	001-35955
Entity Registrant Name	Vuzix Corp
Entity Incorporation, State or Country Code	DE
Entity Central Index Key	0001463972
Entity Tax Identification Number	04-3392453
Entity Address, Address Line One	25 Hendrix Road, Suite A
Entity Address, City or Town	West Henrietta
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14586
City Area Code	585
Local Phone Number	359-5900
Title of 12(b) Security	Common Stock
Trading Symbol	VUZI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		63,667,941
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash and Cash Equivalents	$ 113,329,734	$ 120,203,873
Accounts Receivable	1,551,654	2,242,429
Inventories, Net	12,559,066	12,151,982
Manufacturing Vendor Prepayments	586,564	504,051
Prepaid Expenses and Other Assets	1,470,415	2,047,819
Total Current Assets	129,497,433	137,150,154
Long-Term Assets
Fixed Assets, Net	5,042,421	5,190,438
Operating Lease Right-of-Use Asset	968,269	1,117,022
Patents and Trademarks, Net	2,020,099	1,988,370
Licenses, Net	1,333,236	1,389,936
Intangible Asset, Net	42,821	147,548
Other Assets, Net	1,445,897	1,483,589
Total Assets	140,350,176	148,467,057
Current Liabilities
Accounts Payable	1,223,741	2,054,762
Unearned Revenue	29,623	27,797
Accrued Expenses	1,127,021	1,419,308
Income and Other Taxes Payable	45,692	120,242
Operating Lease Right-of-Use Liability	514,204	534,146
Total Current Liabilities	2,940,281	4,156,255
Long-Term Liabilities
Operating Lease Right-of-Use Liability	454,065	582,876
Total Liabilities	3,394,346	4,739,131
Stockholders' Equity
Common Stock - $0.001 Par Value, 100,000,000 Shares Authorized; 63,704,626 shares issued and 63,667,941 share outstanding as of March 31, 2022 and 63,672,268 Shares Issued and Outstanding as of December 31, 2021	63,705	63,672
Additional Paid-in Capital	350,721,326	346,736,397
Accumulated Deficit	(213,578,144)	(203,072,143)
Treasury Stock, at cost, 36,685 shares as of March 31, 2022 and 0 shares as of December 31, 2021	(251,057)
Total Stockholders' Equity	136,955,830	143,727,926
Total Liabilities and Stockholders' Equity	$ 140,350,176	$ 148,467,057

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
CONSOLIDATED BALANCE SHEETS
Preferred Stock, Par Value	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares Issued	63,704,626	63,672,268
Common Stock, Shares Outstanding	63,667,941	63,672,268
Treasury Stock, Shares	36,685	0

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock, at Cost	Total
Balance at Dec. 31, 2020	$ 50	$ 45,645	$ 210,952,473	$ (162,694,983)		$ 48,303,185
Balance (in shares) at Dec. 31, 2020	49,626	45,645,166
Stock-Based Compensation Expense			2,047,378			2,047,378
Stock Option Exercises		$ 231	196,597			196,828
Stock Option Exercises (in shares)		230,968
Stock Warrant Exercises		$ 7,241	34,561,297			34,568,538
Stock Warrant Exercises (in shares)		7,241,028
Proceeds from Common Stock Offerings		$ 4,146	84,995,865			85,000,011
Proceeds from Common Stock Offerings (in shares)		4,146,342
Direct Costs of Common Stock Offerings			(5,396,139)			(5,396,139)
Shares Redeemed to Cover Employee Tax Withholdings		$ (83)	(1,144,283)			(1,144,366)
Shares Redeemed to Cover Employee Tax Withholdings (in shares)		(83,164)
Preferred Stock Converted & Preferred Dividend Settlement	$ (50)	$ 4,962	(10,004,912)			(10,000,000)
Net Loss				(9,151,370)		(9,151,370)
Balance at Mar. 31, 2021		$ 62,142	316,208,276	(171,846,353)		144,424,065
Balance (in shares) at Mar. 31, 2021		62,142,940
Preferred Stock Converted & Preferred Dividend Settlement (in shares)	(49,626)	4,962,600
Balance at Dec. 31, 2021		$ 63,672	346,736,397	(203,072,143)		143,727,926
Balance (in shares) at Dec. 31, 2021		63,672,268
Stock-Based Compensation Expense			3,955,738			3,955,738
Stock Option Exercises		$ 33	29,191			29,224
Stock Option Exercises (in shares)		32,358
Purchases of Treasury Stock					$ (251,057)	$ (251,057)
Purchases of Treasury Stock (in Shares)					(36,685)	(36,685)
Net Loss				(10,506,001)		$ (10,506,001)
Balance at Mar. 31, 2022		$ 63,705	$ 350,721,326	$ (213,578,144)	$ 251,057	$ 136,955,830
Balance (in shares) at Mar. 31, 2022		63,704,626			36,685

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Sales:
Total Sales	$ 2,503,051	$ 3,915,389
Cost of Sales:
Total Cost of Sales	1,863,697	2,835,798
Gross Profit (exclusive of depreciation shown separately below)	639,354	1,079,591
Operating Expenses:
Research and Development	3,103,444	2,205,318
Selling and Marketing	2,023,435	1,303,430
General and Administrative	5,453,833	6,027,757
Depreciation and Amortization	422,931	517,412
Loss on Fixed Asset Disposal		83,908
Impairment of Patents and Trademarks	49,603	27,731
Total Operating Expenses	11,053,246	10,165,556
Loss From Operations	(10,413,892)	(9,085,965)
Other Income (Expense):
Investment Income	6,280	7,838
Income and Other Taxes	(47,632)	(19,725)
Foreign Exchange Loss	(50,757)	(53,518)
Total Other Expense, Net	(92,109)	(65,405)
Loss Before Provision for Income Taxes	(10,506,001)	(9,151,370)
Net Loss	$ (10,506,001)	$ (9,151,370)
Basic Loss per Common Share	$ (0.16)	$ (0.17)
Diluted Loss per Common Share	$ (0.16)	$ (0.17)
Weighted-average Shares Outstanding - Basic	63,695,127	54,141,761
Weighted-average Shares Outstanding - Diluted	63,695,127	54,141,761
Sales of Products
Sales:
Total Sales	$ 2,503,051	$ 3,805,170
Cost of Sales:
Cost of Sales	$ 1,863,697	2,819,971
Sales of Engineering Services
Sales:
Total Sales		110,219
Cost of Sales:
Cost of Sales		$ 15,827

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities
Net Loss	$ (10,506,001)	$ (9,151,370)
Non-Cash Adjustments
Depreciation and Amortization	422,931	517,412
Amortization of Software Development Costs and Prepaid Licenses in Cost of Sales - Products	60,099	60,099
Stock-Based Compensation	4,319,748	4,618,213
Impairment of Patents and Trademarks	49,603	27,731
Loss on Fixed Asset Disposal		83,908
(Increase) Decrease in Operating Assets
Accounts Receivable	690,775	91,973
Revenues in Excess of Billings		(40,856)
Inventories	(407,084)	(857,695)
Manufacturing Vendor Prepayments	(82,513)	(1,785,763)
Prepaid Expenses and Other Assets	213,394	142,685
Increase (Decrease) in Operating Liabilities
Accounts Payable	(831,021)	(191,028)
Accrued Expenses	(292,286)	646,048
Unearned Revenue	1,825	(17,698)
Income and Other Taxes	(74,549)	(65,288)
Net Cash Flows Used in Operating Activities	(6,435,079)	(5,921,629)
Cash Flows from Investing Activities
Purchases of Fixed Assets	(57,758)	(314,981)
Investments in Patents and Trademarks	(34,469)	(135,674)
Investments in Licenses, Intangible and Other Assets	(125,000)	(200,000)
Net Cash Flows Used in Investing Activities	(217,227)	(650,655)
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants		34,568,538
Proceeds from Exercise of Stock Options	29,224	196,828
Proceeds from Common Stock Offering, Net		79,603,872
Preferred Dividend Settlement Payment		(10,000,000)
Employee Tax Withholdings Payment		(1,144,366)
Purchases of Treasury Stock	(251,057)
Net Cash Flows Provided from Financing Activities	(221,833)	103,224,872
Net Increase in Cash and Cash Equivalents	(6,874,139)	96,652,588
Cash and Cash Equivalents - Beginning of Period	120,203,873	36,069,508
Cash and Cash Equivalents - End of Period	113,329,734	132,722,096
Supplemental Disclosures
Unamortized Common Stock Expense included in Prepaid Expenses and Other Assets	1,001,232	160,222
Stock-Based Compensation Expense - Expensed less Previously Issued	$ 364,010	$ 58,828

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2022

Basis of Presentation

Basis of Presentation

Note 1 – Basis of Presentation

The accompanying unaudited consolidated financial statements of Vuzix Corporation (“the Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, the unaudited consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Certain re-classifications may have been made to prior periods to conform with current reporting. The results of the Company’s operations for the three months ended March 31, 2022 are not necessarily indicative of the results of the Company’s operations for the full fiscal year or any other period.

The accompanying interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto of the Company as of December 31, 2021, as reported in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2022.

Restatement

As described in additional detail in Note 14 to the financial statements included in its 2021 Form 10-K, the Company restated its previous unaudited quarterly results in the Form 10-K for the year ended December 31, 2021. Previously filed 2021 quarterly reports on Form 10-Q for the periods affected by the restatement were not amended. See Note 14, Long-Term Incentive Plan and Note 19, Quarterly Financial Information (Unaudited) of the Notes to the consolidated financial statements in the 2021 Form 10-K for the impact of these adjustments on each of the quarterly periods in fiscal year 2021.

The effect of these changes on non-cash stock-based compensation expense included in 2021 unaudited quarterly operating results was as follows:

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05

Customer Concentrations

For the three months ended March 31, 2022, one customer represented 11% of total product revenue. For the three months ended March 31, 2021, one customer represented 11% of total product revenue and one customer represented 100% of engineering services revenue.

As of March 31, 2022, three customers represented 22%, 14% and 13% of accounts receivable. As of December 31, 2021, three customers represented 27%, 20% and 10% of accounts receivable.

Treasury Stock

Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains and losses on the subsequent reissuance of shares will be credited or charged to paid-in capital in excess of par value using the average-cost method.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). ASU 2016-13 provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets and certain other instruments, including but not limited to accounts receivable. ASU 2016-13 will become effective for the Company on January 1, 2023 and early adoption is permitted. The Company does not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

XML

Revenue Recognition and Contracts with Customers

3 Months Ended

Mar. 31, 2022

Revenue Recognition and Contracts with Customers

Revenue Recognition and Contracts with Customers

Note 2 – Revenue Recognition and Contracts with Customers

Disaggregated Revenue

The Company’s total revenue was comprised of two major product lines: Smart Glasses Sales and Engineering Services. The following table summarizes the revenue recognized by major product line:

	Three Months Ended
	March 31,
	2022		2021
Revenues
Smart Glasses Sales	$	2,503,051	$	3,805,170
Engineering Services		—		110,219
Total Revenue	$	2,503,051	$	3,915,389

Significant Judgments

Under Topic 606 “Revenue from Contracts with Customers”, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized by major product line. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include an end-user 30-day right to return if not satisfied with product and general payment terms that are between Net 30 and 60 days. For our engineering services, performance obligations are recognized over time using the input method and the estimated costs to complete each project are considered significant judgments.

Performance Obligations

Revenues from our performance obligations are typically satisfied at a point in time for Smart Glasses, Waveguides and Display Engines, and our OEM Products, which are recognized when the customer obtains control and ownership, which is generally upon shipment. The Company also records revenue for performance obligations relating to our engineering services over time by using the input method measuring progress toward satisfying the performance obligations. Satisfaction of our performance obligations related to our engineering services is measured by the Company’s costs incurred as a percentage of total expected costs to project completion as the inputs of actual costs incurred by the Company are directly correlated with progress toward completing the contract. As such, the Company believes that our methodologies for recognizing revenue over time for our engineering services correlate directly with the transfer of control of the underlying assets to our customers.

Our standard product sales include a twelve (12) month assurance-type product warranty. In the case of certain of our OEM products and waveguide sales, some include a standard product warranty of up to eighteen (18) months to allow distribution channels to offer the end customer a full twelve (12) months of coverage. We offer extended warranties to customers, which extend the standard product warranty on product sales for an additional twelve (12) month period. All revenue related to extended product warranty sales is deferred and recognized over the extended warranty period. Our engineering services contracts vary from contract to contract but typically include payment terms of Net 30 days from date of billing, subject to an agreed upon customer acceptance period.

The following table presents a summary of the Company’s sales by revenue recognition method as a percentage of total net sales for the three months ended March 31, 2022:

	% of Total Net Sales
	2022		2021
Point-in-Time	100	%	97	%
Over Time – Input Method	-	%	3	%
Total	100	%	100	%

Remaining Performance Obligations

As of March 31, 2022, the Company had no outstanding performance obligations for its engineering services and waveguide development projects. In addition, the Company had no material outstanding performance obligations related to product sales, other than its standard product warranty.

XML

Loss Per Share

3 Months Ended

Mar. 31, 2022

Loss Per Share

Loss Per Share

Note 3 – Loss Per Share

Basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are anti-dilutive. Since the Company reported a net loss for the three months ended March 31, 2022 and 2021, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. At March 31, 2022 and 2021, there were 8,611,365 and 8,983,727 common stock share equivalents, respectively, potentially exercisable or issuable under conversion or exercise of stock options that could dilute basic earnings per share in the future.

XML

Inventories, Net

3 Months Ended

Mar. 31, 2022

Inventories, Net

Inventories, Net

Note 4 – Inventories, Net

Inventories are stated at the lower of cost and net realizable value, and consisted of the following:

	March 31,		December 31,
	2022		2021
Purchased Parts and Components	$	11,461,309	$	11,580,766
Work-in-Process		265,757		226,126
Finished Goods		1,959,141		1,472,534
Less: Reserve for Obsolescence		(1,127,141)		(1,127,444)
Inventories, Net	$	12,559,066	$	12,151,982

XML

Licenses, Net

3 Months Ended

Mar. 31, 2022

Licenses, Net

Licenses, Net

Note 5 – Licenses, Net

	March 31,		December 31,
	2022		2021
Licenses	$	2,443,356	$	1,038,606
Additions		—		1,404,750
Less: Accumulated Amortization		(1,110,120)		(1,053,420)
Licenses, Net	$	1,333,236	$	1,389,936

The Company acquired two licenses in 2017. The first related to the renegotiation of an existing license at a cost of $114,967, which resulted in lower royalty rates being paid by the Company over the next ten years. This license went into effect as of January 1, 2018. The second license was a result of the Company entering into a Technology Purchase and Royalty Agreement where it acquired all the seller’s right, title and interest in certain Transferred Intellectual Property (IP). Pursuant to the agreement, the Company paid approximately $75,702 as reimbursement of related patent application costs incurred by the seller to date, which are included in Patents and Trademarks. The Company also issued 25,000 shares of common stock, valued at $128,750, upon the original closing in October 2017 and agreed to certain further share issuances of 75,000 shares based upon the achievement of certain development milestones as well as per unit royalties once the technology was commercialized for the life of the related patents. In June 2021, the Company assumed or purchased outright the obligations for ongoing royalties under the original license agreement and certain other intellectual property rights in connection with consulting services by the original seller in exchange for the issuance of 75,000 shares with an assigned market value of $18.73 per share, or a total of $1,404,750. The underlying technology is not yet ready for commercialization, but the Company intends to proceed with further research and development work relating to such underlying technology.

XML

Intangible Asset, Net

3 Months Ended

Mar. 31, 2022

Intangible Asset, Net

Intangible Asset, Net

Note 6 – Intangible Asset, Net

	March 31,		December 31,
	2022		2021
Intangible Asset	$	1,500,000	$	1,500,000
Less: Accumulated Amortization		(1,457,179)		(1,352,452)
Intangible Asset, Net	$	42,821	$	147,548

On October 4, 2018, the Company entered into amendment No. 1 to agreements (the “TDG Amendment”) with TDG Acquisition Company, LLC (“TDG”), aka Six15 Technologies, LLC. The TDG Amendment amends certain provisions of prior agreements between Vuzix and TDG, including an asset purchase agreement dated June 15, 2012, and an authorized reseller agreement dated June 15, 2012.

Pursuant to the TDG Amendment, the Company is permitted to engage in sales of heads-up display components or subsystems (and any services to support such sale) for incorporation into a finished good or system for sale to military organizations, subject to certain conditions. The Company is also permitted to sell its products to defense and security organizations that include business customers and governmental entity customers that primarily provide security and defense services, including police, fire fighters, EMTs, other first responders, and homeland and border security. The Company will owe TDG commissions with respect to all such sales until June 15, 2022, when the amendment and original non-compete agreements expire, after which the Company will be permitted to sell any product to any customer world-wide without owing any commission to TDG.

Total commissions expense under this agreement for the three months ended March 31, 2022 and 2021 was $25,794 and $52,655. All commissions expense related to this agreement is included in Selling and Marketing expense.

Total amortization expense for this intangible asset for the three months ended March 31, 2022 and 2021 was $104,727 and $104,727, respectively. $42,821 of remaining amortization expense will be recognized in the second quarter of 2022, as the non-compete agreement with TDG expires on June 15, 2022.

XML

Other Assets

3 Months Ended

Mar. 31, 2022

Other Assets

Other Assets

Note 7 - Other Assets

	March 31,		December 31,
	2022		2021
Private Corporation Investments (at cost)	$	450,000	$	450,000
Software Development Costs		750,000		500,000
Additions		125,000		250,000
Less: Accumulated Amortization		(250,000)		(208,334)
Software Development Costs, Net		625,000		541,666
Unamortized Common Stock Expense included in Long-Term Prepaid Expenses		370,897		491,923
Total Other Assets	$	1,445,897	$	1,483,589

During 2020, the Company invested $500,000 in Android operating systems upgrades for its CPU platform used on its M400 and M4000 products. This upgrade was finished and placed into service in the beginning of the fourth quarter of 2020.  This capitalized asset is being amortized on a straight-line over its expected product life cycle of 36 months, which began on October 1, 2020. In October 2021, the Company invested $250,000 and in the first quarter of 2022 the Company invested an additional $125,000 for further Android operating systems version upgrades to the CPU platform it uses on its M400 and M4000 products. This development work has not yet been completed and will ultimately be amortized once placed into service which the Company expects to occur by early 2023.

XML

Accrued Expenses

3 Months Ended

Mar. 31, 2022

Accrued Expenses

Accrued Expenses

Note 8 – Accrued Expenses

Accrued expenses consisted of the following:

	March 31,		December 31,
	2022		2021
Accrued Wages and Related Costs	$	484,980	$	683,044
Accrued Professional Services		318,231		551,220
Accrued Warranty Obligations		156,192		185,044
Other Accrued Expenses		167,618		—
Total	$	1,127,021	$	1,419,308

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally twelve (12) months. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued expense at the time of sale. The Company estimates its future warranty costs based upon product-based historical performance rates and related costs to repair.

The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2022 and the balance as of December 31, 2021 were as follows:

Accrued Warranty Obligations at December 31, 2021	$	185,044
Reductions for Settling Warranties		(103,943)
Warranties Issued During Year		75,091
Accrued Warranty Obligations at March 31, 2022	$	156,192

XML

Income Taxes

3 Months Ended

Mar. 31, 2022

Income Taxes

Income Taxes

Note 9 – Income Taxes

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

XML

Capital Stock

3 Months Ended

Mar. 31, 2022

Capital Stock

Capital Stock

Note 10 – Capital Stock

Preferred stock

The Board of Directors is authorized to establish and designate different series of preferred stock and to fix and determine their voting powers and other rights and terms. A total of 5,000,000 shares of preferred stock with a par value of $0.001 are authorized as of March 31, 2022 and December 31, 2021. Of this total, 49,626 shares are designated as Series A Preferred Stock. There were nil shares of Series A Preferred Stock issued and outstanding on March 31, 2022 and December 31, 2021, respectively.

Common Stock

The Company’s authorized common stock consists of 100,000,000 shares, par value of $0.001. There were 63,704,626 shares issued and 63,667,941 shares outstanding as of March 31, 2022 and 63,672,268 shares issued and outstanding as of December 31, 2021.

Treasury Stock

On March 2, 2022, our Board of Directors approved the repurchase by the Company of up to an aggregate of $25 million of our common stock by open market or privately negotiated transactions under the Share Buyback Program.  This program is in effect for one year, does not obligate the Company to acquire any particular amount of common stock and  may be suspended or discontinued at any time at the Company’s sole discretion. During the three months ended March 31, 2022, the Company repurchased 36,685 shares of our common stock at an average cost of $6.84. As of March 31, 2022, 36,685 shares of our common stock were held in treasury.

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2022

Stock-Based Compensation

Stock-Based Compensation

Note 11 – Stock-Based Compensation

A summary of stock option activity related to the Company’s standard employee incentive plan, excluding options awarded under the Long-Term Incentive Plan (LTIP), for the three months ended March 31, 2022 is as follows:

		Weighted
	Number of	Average
	Options	Exercise Price
Outstanding at December 31, 2021	2,823,634	$	7.67
Granted	98,500		5.78
Exercised	(43,040)		3.94
Expired or Forfeited	(51,729)		8.60
Outstanding at March 31, 2022	2,827,365	$	7.74

The weighted average remaining contractual term for all options as of March 31, 2022 and December 31, 2021 was 7.74 years and 7.95 years, respectively.

As of March 31, 2022, there were 1,183,727 options that were fully-vested and exercisable at a weighted average exercise price of $6.04 per share. The weighted average remaining contractual term of the vested options is 6.6 years.

As of March 31, 2022, there were 1,643,638 unvested options exercisable at a weighted average exercise price of $9.83 per share. The weighted average remaining contractual term of the unvested options is 8.6 years.

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At March 31, 2022, the Company had $8,353,781 of unrecognized stock compensation expense, which will be recognized over a weighted average period of 3.0 years.

For the three months ended March 31, 2022 and 2021, the Company recorded total stock-based compensation expense, including stock awards but excluding awards under the Company’s LTIP, of $1,350,610 and $456,745, respectively.

XML

Long-term Incentive Plan

3 Months Ended

Mar. 31, 2022

Long-term Incentive Plan

Long-term Incentive Plan

Note 12 – Long-Term Incentive Plan

On March 17, 2021, the Company granted options to purchase a total of 5,784,000 shares of common stock to its officers and certain other members of its management team. The options were granted under the Company’s existing 2014 Incentive Stock Plan. The options have an exercise price of $19.00, with 375,000 options vesting immediately and the remaining portion vesting upon the achievement of certain equity market capitalization milestones, and revenue and EBITDA operational milestones. For the three months ended March 31, 2022 and 2021, the Company recorded non-cash stock-based compensation expense of $2,969,138 and $4,161,468, respectively, for options that vested or are probable to vest.

The fair value of option grants was calculated using a Monte Carlo simulation on the equity market capitalization tranches and the Black-Scholes-Merton option pricing method on the operational milestone tranches. As of March 31, 2022, we had $25,371,320 of total unrecognized stock-based compensation expense for the portion of options tied to equity market capitalization milestones and the portion of options tied to operational milestones that were considered probable of achievement, all of which will be recognized over a service period of up to six years. The probabilities of the milestone achievements are subject to catch-adjustments in each instance where an equity market capitalization milestone is achieved or when an operational milestone becomes probable to be achieved or is achieved. Compensation costs could be reversed in subsequent periods if an awardee leaves the Company prior to the expiration of the option life for market capitalization milestone or the performance awards are no longer determined to be probable. If such milestones are achieved earlier in their expected service periods, the remaining unrecognized compensation expense related to that particular milestone would be accelerated and recognized in full during the period where that achievement is affirmed by the Board of Directors. As of March 31, 2022, and going forward, should all of the operational milestones which are currently not yet deemed probable of achievement become probable of achievement or are achieved, then the Company could ultimately recognize up to an additional $34.1 million in non-cash stock-based compensation expense at such time.

The unvested remaining equity market capitalization and operational milestones under the LTIP with their total related option grants and criteria achievement weightings of the options available for meeting a target are shown in the following table. Of the total 5,409,000 unvested options outstanding as of March 31, 2022 and December 31, 2021, there are 2,704,500 options unvested for the achievement of equity market capitalization targets, 1,893,150 unvested options

for the achievement of annual revenue targets, and 811,350 unvested options for the achievement of annual EBITDA margins before non-cash charges targets.

Award Potential	Criteria Achievement Weighting
	50% of Options Available	35% of Options Available	15% of Options Available
Options Available (Subject to Vesting)	Equity Market Capitalization Target	Last Twelve Months Revenue Target	Last Twelve Months EBITDA Margin before Non-Cash Charges Target
686,000	$ 2,000,000,000	$ 25,000,000	0.0%
686,000	3,000,000,000	50,000,000	2.0%
686,000	4,000,000,000	100,000,000	4.0%
686,000	5,000,000,000	200,000,000	6.0%
586,000	6,000,000,000	300,000,000	8.0%
586,000	7,000,000,000	450,000,000	10.0%
561,000	8,000,000,000	675,000,000	12.0%
491,000	9,000,000,000	1,000,000,000	14.0%
441,000	10,000,000,000	1,500,000,000	16.0%
5,409,000

XML

Litigation

3 Months Ended

Mar. 31, 2022

Litigation

Litigation

Note 13 – Litigation

We are not currently involved in any actual or pending legal proceeding or litigation and we are not aware of any such material proceedings contemplated by or against us or involving our property.

XML

Right-of-Use Assets and Liabilities

3 Months Ended

Mar. 31, 2022

Right-of-Use Assets and Liabilities

Right-of-Use Assets and Liabilities

Note 14 – Right-of-Use Assets and Liabilities

Future lease payments under operating leases as of March 31, 2022 were as follows:

2022	$	417,750
2023		546,916
2024		45,576
Total Future Lease Payments		1,010,242
Less: Imputed Interest		(41,973)
Total Lease Liability Balance	$	968,269

Operating lease costs under the operating leases totaled $162,365 and $124,215 for the three months ended March 31, 2022 and 2021, respectively.

As of March 31, 2022, the weighted average discount rate was 4.5% and the weighted average remaining lease term was 1.8 years.

XML

Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2022

Basis of Presentation

Basis of Presentation

The accompanying unaudited consolidated financial statements of Vuzix Corporation (“the Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, the unaudited consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Certain re-classifications may have been made to prior periods to conform with current reporting. The results of the Company’s operations for the three months ended March 31, 2022 are not necessarily indicative of the results of the Company’s operations for the full fiscal year or any other period.

The accompanying interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto of the Company as of December 31, 2021, as reported in the Company’s Annual Report on Form 10-K filed with the SEC on March 2, 2022.

Restatement

Restatement

As described in additional detail in Note 14 to the financial statements included in its 2021 Form 10-K, the Company restated its previous unaudited quarterly results in the Form 10-K for the year ended December 31, 2021. Previously filed 2021 quarterly reports on Form 10-Q for the periods affected by the restatement were not amended. See Note 14, Long-Term Incentive Plan and Note 19, Quarterly Financial Information (Unaudited) of the Notes to the consolidated financial statements in the 2021 Form 10-K for the impact of these adjustments on each of the quarterly periods in fiscal year 2021.

The effect of these changes on non-cash stock-based compensation expense included in 2021 unaudited quarterly operating results was as follows:

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05

Customer Concentrations

Customer Concentrations

For the three months ended March 31, 2022, one customer represented 11% of total product revenue. For the three months ended March 31, 2021, one customer represented 11% of total product revenue and one customer represented 100% of engineering services revenue.

As of March 31, 2022, three customers represented 22%, 14% and 13% of accounts receivable. As of December 31, 2021, three customers represented 27%, 20% and 10% of accounts receivable.

Treasury Stock

Treasury Stock

Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains and losses on the subsequent reissuance of shares will be credited or charged to paid-in capital in excess of par value using the average-cost method.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). ASU 2016-13 provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets and certain other instruments, including but not limited to accounts receivable. ASU 2016-13 will become effective for the Company on January 1, 2023 and early adoption is permitted. The Company does not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.

XML

Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2022

Basis of Presentation

Schedule of effect of changes on actual stock-based compensation expense

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05

XML

Revenue Recognition and Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2022

Revenue Recognition and Contracts with Customers

Schedule of company's total revenue by major product lines

	Three Months Ended
	March 31,
	2022		2021
Revenues
Smart Glasses Sales	$	2,503,051	$	3,805,170
Engineering Services		—		110,219
Total Revenue	$	2,503,051	$	3,915,389

Schedule of company's net sales by revenue recognition method as a percentage of total net sales

The following table presents a summary of the Company’s sales by revenue recognition method as a percentage of total net sales for the three months ended March 31, 2022:

	% of Total Net Sales
	2022		2021
Point-in-Time	100	%	97	%
Over Time – Input Method	-	%	3	%
Total	100	%	100	%

XML

Inventories, Net (Tables)

3 Months Ended

Mar. 31, 2022

Inventories, Net

Schedule of Inventories

	March 31,		December 31,
	2022		2021
Purchased Parts and Components	$	11,461,309	$	11,580,766
Work-in-Process		265,757		226,126
Finished Goods		1,959,141		1,472,534
Less: Reserve for Obsolescence		(1,127,141)		(1,127,444)
Inventories, Net	$	12,559,066	$	12,151,982

XML

Licenses, Net (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of Finite-Lived Intangible Assets

	March 31,		December 31,
	2022		2021
Intangible Asset	$	1,500,000	$	1,500,000
Less: Accumulated Amortization		(1,457,179)		(1,352,452)
Intangible Asset, Net	$	42,821	$	147,548

Licenses [Member]

Schedule of Finite-Lived Intangible Assets

	March 31,		December 31,
	2022		2021
Licenses	$	2,443,356	$	1,038,606
Additions		—		1,404,750
Less: Accumulated Amortization		(1,110,120)		(1,053,420)
Licenses, Net	$	1,333,236	$	1,389,936

XML

Intangible Asset, Net (Tables)

3 Months Ended

Mar. 31, 2022

Intangible Asset, Net

Schedule of Finite-Lived Intangible Assets

	March 31,		December 31,
	2022		2021
Intangible Asset	$	1,500,000	$	1,500,000
Less: Accumulated Amortization		(1,457,179)		(1,352,452)
Intangible Asset, Net	$	42,821	$	147,548

XML

Other Assets (Tables)

3 Months Ended

Mar. 31, 2022

Other Assets

Schedule of other assets

	March 31,		December 31,
	2022		2021
Private Corporation Investments (at cost)	$	450,000	$	450,000
Software Development Costs		750,000		500,000
Additions		125,000		250,000
Less: Accumulated Amortization		(250,000)		(208,334)
Software Development Costs, Net		625,000		541,666
Unamortized Common Stock Expense included in Long-Term Prepaid Expenses		370,897		491,923
Total Other Assets	$	1,445,897	$	1,483,589

XML

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2022

Accrued Expenses

Schedule of Accrued Expenses

Accrued expenses consisted of the following:

	March 31,		December 31,
	2022		2021
Accrued Wages and Related Costs	$	484,980	$	683,044
Accrued Professional Services		318,231		551,220
Accrued Warranty Obligations		156,192		185,044
Other Accrued Expenses		167,618		—
Total	$	1,127,021	$	1,419,308

Schedule of changes in accrued warranty obligations

The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2022 and the balance as of December 31, 2021 were as follows:

Accrued Warranty Obligations at December 31, 2021	$	185,044
Reductions for Settling Warranties		(103,943)
Warranties Issued During Year		75,091
Accrued Warranty Obligations at March 31, 2022	$	156,192

XML

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Stock-Based Compensation

Schedule of Summary of Stock Option Activity

A summary of stock option activity related to the Company’s standard employee incentive plan, excluding options awarded under the Long-Term Incentive Plan (LTIP), for the three months ended March 31, 2022 is as follows:

		Weighted
	Number of	Average
	Options	Exercise Price
Outstanding at December 31, 2021	2,823,634	$	7.67
Granted	98,500		5.78
Exercised	(43,040)		3.94
Expired or Forfeited	(51,729)		8.60
Outstanding at March 31, 2022	2,827,365	$	7.74

XML

Long-term Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2022

Long-term Incentive Plan

Schedule of effect of changes on actual stock-based compensation expense

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05

Schedule of equity market and operational milestone under the long term

Award Potential	Criteria Achievement Weighting
	50% of Options Available	35% of Options Available	15% of Options Available
Options Available (Subject to Vesting)	Equity Market Capitalization Target	Last Twelve Months Revenue Target	Last Twelve Months EBITDA Margin before Non-Cash Charges Target
686,000	$ 2,000,000,000	$ 25,000,000	0.0%
686,000	3,000,000,000	50,000,000	2.0%
686,000	4,000,000,000	100,000,000	4.0%
686,000	5,000,000,000	200,000,000	6.0%
586,000	6,000,000,000	300,000,000	8.0%
586,000	7,000,000,000	450,000,000	10.0%
561,000	8,000,000,000	675,000,000	12.0%
491,000	9,000,000,000	1,000,000,000	14.0%
441,000	10,000,000,000	1,500,000,000	16.0%
5,409,000

XML

Right-of-Use Assets and Liabilities (Tables)

3 Months Ended

Mar. 31, 2022

Right-of-Use Assets and Liabilities

Schedule of Future lease payments under operating leases

Future lease payments under operating leases as of March 31, 2022 were as follows:

2022	$	417,750
2023		546,916
2024		45,576
Total Future Lease Payments		1,010,242
Less: Imputed Interest		(41,973)
Total Lease Liability Balance	$	968,269

XML

Basis of Presentation (Details) - customer	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Total revenues [Member]
Number of customers	1	1
Accounts Receivable [Member]
Number of customers	3		3
One customer | Sales of Engineering Services
Number of customers		1
One customer | Total revenues [Member] | Customer Concentration Risk
Concentration Risk, Percentage	11.00%	11.00%
One customer | Total revenues [Member] | Sales of Engineering Services | Customer Concentration Risk
Concentration Risk, Percentage		100.00%
One customer | Accounts Receivable [Member] | Customer Concentration Risk
Concentration Risk, Percentage	22.00%		27.00%
Two customers | Accounts Receivable [Member] | Customer Concentration Risk
Concentration Risk, Percentage	14.00%		20.00%
Three customers | Accounts Receivable [Member] | Customer Concentration Risk
Concentration Risk, Percentage	13.00%		10.00%

XML

Basis of Presentation - Restatement (Details) - Equity Market Capitalization Targets [Member] - Long-term Incentive Plan 2021	3 Months Ended
	Mar. 31, 2021 USD ($) $ / shares
Additional Paid-in Capital	$ 2,512,007
Research and Development Expense	125,391
Sales and Marketing	62,696
General and Administrative	2,323,920
Net Loss	$ 2,512,007
Loss per Share | $ / shares	$ 0.05

XML

Revenue Recognition and Contracts with Customers - Company's total revenue by major product lines (Details)	3 Months Ended
	Mar. 31, 2022 USD ($) product	Mar. 31, 2021 USD ($)
Revenue	$ 2,503,051	$ 3,915,389
Number of major product lines | product	2
Smart Glasses Sales
Revenue	$ 2,503,051	3,805,170
Engineering Services
Revenue		$ 110,219

XML

Revenue Recognition and Contracts with Customers - Company's net sales as a percentage (Details)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue Performance Obligation Percentage	100.00%	100.00%
Point-in-Time - Output Method [Member]
Revenue Performance Obligation Percentage	100.00%	97.00%
Over Time - Input Method [Member]
Revenue Performance Obligation Percentage		3.00%

XML

Revenue Recognition and Contracts with Customers - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022 USD ($)
Standard Product Warranty Term	12 months
Revenue, Remaining Performance Obligation	$ 0
Extended warranties
Standard Product Warranty Term	12 months
OEM products and waveguide sales
Standard Product Warranty Term	18 months

XML

Loss Per Share - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Loss Per Share
Earnings Per Share, Potentially Dilutive Securities	8,611,365	8,983,727

XML

Inventories, Net - Components of Inventories (Detail) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Inventories, Net
Purchased Parts and Components	$ 11,461,309	$ 11,580,766
Work in Process	265,757	226,126
Finished Goods	1,959,141	1,472,534
Less: Reserve for Obsolescence	(1,127,141)	(1,127,444)
Inventories, Net	$ 12,559,066	$ 12,151,982

XML

Licenses, Net (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Licenses Net [Line Items]
Licenses, Net	$ 1,333,236	$ 1,389,936
Licensing agreements
Licenses Net [Line Items]
Licenses	2,443,356	1,038,606
Additions		1,404,750
Less: Accumulated Amortization / Expensed	(1,110,120)	(1,053,420)
Licenses, Net	$ 1,333,236	$ 1,389,936

XML

Licenses, Net - Additional Information (Details)	1 Months Ended	3 Months Ended		12 Months Ended
	Jun. 30, 2021 USD ($) $ / shares shares	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2017 USD ($) item shares	Dec. 31, 2021 USD ($)
Licenses Net [Line Items]
Purchase price		$ 34,469	$ 135,674
Shares issued value			85,000,011
Research and Development		$ 3,103,444	$ 2,205,318
Licensing agreements
Licenses Net [Line Items]
Number of license acquired | item				2
Value of shares development milestones					$ 1,404,750
First license agreements
Licenses Net [Line Items]
Licenses, Net				$ 114,967
Amortization period (in years)				10 years
Second license agreements
Licenses Net [Line Items]
Patent application costs				$ 75,702
Company awarded shares | shares				25,000
Shares issued value				$ 128,750
Issuance of shares development milestones | shares	75,000			75,000
Market value per share | $ / shares	$ 18.73
Value of shares development milestones	$ 1,404,750

XML

Intangible Asset, Net - Schedule of Finite-Lived Intangible Assets (Details) - Intangible Assets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Intangible Asset	$ 1,500,000	$ 1,500,000
Less: Accumulated Amortization	(1,457,179)	(1,352,452)
Intangible Asset, Net	$ 42,821	$ 147,548

XML

Intangible Asset, Net - Additional Information (Details) - TDG Acquisition Company LLC [Member] - USD ($)	3 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Mar. 31, 2021
Amortization of intangible assets	$ 42,821	$ 104,727	$ 104,727
Selling and Marketing Expense.
Total commission expense		$ 25,794	$ 52,655

XML

Other Assets (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Oct. 31, 2021	Dec. 31, 2020
Private Corporation Investment	$ 450,000	$ 450,000
Additions	5,042,421	5,190,438
Unamortized Common Stock Expense included in Long-Term Prepaid Expenses	370,897	491,923
Total Other Assets	1,445,897	1,483,589
Software Development
Software development costs	750,000	500,000
Additions	125,000	250,000	$ 250,000	$ 500,000
Less: Accumulated Amortization	(250,000)	(208,334)
Software Development Costs, Net	$ 625,000	$ 541,666

XML

Other Assets - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2022	Dec. 31, 2021	Oct. 31, 2021
Other assets [Line Items]
Additions		$ 5,042,421	$ 5,190,438
Software Development
Other assets [Line Items]
Additions	$ 500,000	$ 125,000	$ 250,000	$ 250,000
Useful life	36 months

XML

Accrued Expenses - Components of Accrued Expenses (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Accrued Expenses
Accrued Wages and Related Costs	$ 484,980	$ 683,044
Accrued Professional Services	318,231	551,220
Accrued Warranty Obligations	156,192	185,044
Other Accrued Expenses	167,618
Total	$ 1,127,021	$ 1,419,308

XML

Accrued Expenses - Changes in Accrued Warranty Obligations (Details)	3 Months Ended
	Mar. 31, 2022 USD ($)
Accrued Expenses
Accrued Warranty Obligations, beginning of period	$ 185,044
Reductions for Settling Warranties	(103,943)
Warranties Issued During Period	75,091
Accrued Warranty Obligations, end of period	$ 156,192

XML

Accrued Expenses - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022
Accrued Expenses
Standard Product Warranty Term	12 months

XML

Capital Stock - Additional Information (Details) - USD ($)		3 Months Ended
	Mar. 02, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Preferred Stock, Shares Authorized		5,000,000		5,000,000
Preferred Stock, Par Value		$ 0.001		$ 0.001
Shares issued value			$ 85,000,011
Common Stock, Shares Authorized		100,000,000		100,000,000
Common Stock, Par or Stated Value Per Share		$ 0.001		$ 0.001
Common Stock, Shares, Issued		63,704,626		63,672,268
Common Stock, Shares, Outstanding		63,667,941		63,672,268
Aggregate value of shares authorized	$ 25
Share repurchase program term	1 year
Shares repurchased		36,685
Average cost		$ 6.84
Common shares held in treasury		36,685
Common Stock
Company awarded shares			4,146,342
Shares issued value			$ 4,146
Preferred Stock Converted & Preferred Dividend Settlement (in shares)			4,962,600
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized		49,626		49,626
Preferred Stock, Shares Issued		0		0
Preferred Stock, Shares Outstanding		0		0

XML

Stock-Based Compensation - Summary of Stock Option Activity (Details) - Stock options	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Number of Options
Outstanding, Beginning Balance | shares	2,823,634
Granted | shares	98,500
Exercised | shares	(43,040)
Expired or Forfeited | shares	(51,729)
Outstanding, Ending Balance | shares	2,827,365
Weighted Average Exercise Price
Outstanding, Beginning Balance | $ / shares	$ 7.67
Granted | $ / shares	5.78
Exercised | $ / shares	3.94
Expired or Forfeited | $ / shares	8.60
Outstanding, Ending Balance | $ / shares	$ 7.74

XML

Stock-Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Stock-Based Compensation Plans
Options Outstanding, Weighted Average Remaining Life (Years)	7 years 8 months 26 days		7 years 11 months 12 days
Exercisable Options Outstanding Shares	1,183,727
Weighted average exercise price per share, Exercisable	$ 6.04
Weighted average remaining contractual term on vested options	6 years 7 months 6 days
Unvested Options Outstanding, Shares	1,643,638
Unvested Options Outstanding, Weighted average exercise price	$ 9.83
Unvested Options Outstanding Weighted average remaining life (years)	8 years 7 months 6 days
Unrecognized stock compensation expense	$ 8,353,781
Weighted average recognition period	3 years
Share-Based compensation excludes the long term incentive plan expense	$ 1,350,610	$ 456,745

XML

Long-term Incentive Plan (Details) - USD ($)		3 Months Ended
	Mar. 17, 2021	Mar. 31, 2022	Mar. 31, 2021
Long-term Incentive Plan
Exercise price		$ 6.04
Share-based Compensation		$ 4,319,748	$ 4,618,213
Unrecognized stock-based compensation expense		$ 8,353,781
Recognition period		3 years
Options available in equity market and operational milestone		5,409,000
Equity Market Capitalization Targets
Long-term Incentive Plan
Options available in equity market and operational milestone		2,704,500
Annual Revenue Targets
Long-term Incentive Plan
Options available in equity market and operational milestone		1,893,150
Annual EBITDA Margins Before Non-Cash Charges Targets
Long-term Incentive Plan
Options available in equity market and operational milestone		811,350
Stock options | Long-term Incentive Plan 2021
Long-term Incentive Plan
Granted	5,784,000
Exercise price	$ 19.00
Share-based Compensation		$ 2,969,138	$ 4,161,468
Stock options | Vest immediately | Long-term Incentive Plan 2021
Long-term Incentive Plan
Options vested	$ 375,000
Stock options tied to equity market capitalization milestone
Long-term Incentive Plan
Unrecognized stock-based compensation expense		25,371,320
Amount of threshold additional stock based compensation expense		$ 34,100,000
Stock options tied to equity market capitalization milestone | Maximum
Long-term Incentive Plan
Recognition period		6 years

XML

Long-term Incentive Plan - LTIP (Details)	3 Months Ended
	Mar. 31, 2022 USD ($) shares
Long-term Incentive Plan
Percentage of weightage for equity market capitalization target	50.00%
Percentage of weightage for last twelve months revenue target	35.00%
Percentage of weightage for last twelve months EBITDA margin before non-cash charges	15.00%
Options available in equity market and operational milestone | shares	5,409,000
Stock option tied to equity market and operational milestones
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	5,409,000
Equity market and operational milestone one
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	686,000
Amount of equity market capitalization target	$ 2,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 25,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	0.00%
Equity market and operational milestone two
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	686,000
Amount of equity market capitalization target	$ 3,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 50,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	2.00%
Equity market and operational milestone three
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	686,000
Amount of equity market capitalization target	$ 4,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 100,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	4.00%
Equity market and operational milestone four
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	686,000
Amount of equity market capitalization target	$ 5,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 200,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	6.00%
Equity market and operational milestone five
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	586,000
Amount of equity market capitalization target	$ 6,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 300,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	8.00%
Equity market and operational milestone six
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	586,000
Amount of equity market capitalization target	$ 7,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 450,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	10.00%
Equity market and operational milestone seven
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	561,000
Amount of equity market capitalization target	$ 8,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 675,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	12.00%
Equity market and operational milestone eight
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	491,000
Amount of equity market capitalization target	$ 9,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 1,000,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	14.00%
Equity market and operational milestone nine
Long-term Incentive Plan
Options available in equity market and operational milestone | shares	441,000
Amount of equity market capitalization target	$ 10,000,000,000
Amount of last twelve months revenue target under the equity market and operational milestone under LTIP	$ 1,500,000,000
Percentage of last twelve months EBITDA margin before non-cash charges target	16.00%

XML

Right-of-Use Assets and Liabilities - Operating Leases (Details)	Mar. 31, 2022 USD ($)
Right-of-Use Assets and Liabilities
2022	$ 417,750
2023	546,916
2024	45,576
Total Future Lease Payments	1,010,242
Less: Imputed Interest	(41,973)
Total Lease Liability Balance	$ 968,269

XML

Right-of-Use Assets and Liabilities - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Right-of-Use Assets and Liabilities
Operating lease costs	$ 162,365	$ 124,215
Weighted average discount rate	4.50%
Weighted average remaining term	1 year 9 months 18 days